Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2002 Mar;57(3):226–230. doi: 10.1136/thorax.57.3.226

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

G Chalmers 1, K Macleod 1, S Little 1, L Thomson 1, C McSharry 1, N Thomson 1
PMCID: PMC1746270  PMID: 11867826

Abstract

Background: Although inhaled corticosteroids have an established role in the treatment of asthma, studies have tended to concentrate on non-smokers and little is known about the possible effect of cigarette smoking on the efficacy of treatment with inhaled steroids in asthma. A study was undertaken to investigate the effect of active cigarette smoking on responses to treatment with inhaled corticosteroids in patients with mild asthma.

Methods: The effect of treatment with inhaled fluticasone propionate (1000 µg daily) or placebo for 3 weeks was studied in a double blind, prospective, randomised, placebo controlled study of 38 steroid naïve adult asthmatic patients (21 non-smokers). Efficacy was assessed using morning and evening peak expiratory flow (PEF) readings, spirometric parameters, bronchial hyperreactivity, and sputum eosinophil counts. Comparison was made between responses to treatment in non-smoking and smoking asthmatic patients.

Results: There was a significantly greater increase in mean morning PEF in non-smokers than in smokers following inhaled fluticasone (27 l/min v –5 l/min). Non-smokers had a statistically significant increase in mean morning PEF (27 l/min), mean forced expiratory volume in 1 second (0.17 l), and geometric mean PC20 (2.6 doubling doses), and a significant decrease in the proportion of sputum eosinophils (–1.75%) after fluticasone compared with placebo. No significant changes were observed in the smoking asthmatic patients for any of these parameters.

Conclusions: Active cigarette smoking impairs the efficacy of short term inhaled corticosteroid treatment in mild asthma. This finding has important implications for the management of patients with mild asthma who smoke.

Full Text

The Full Text of this article is available as a PDF (136.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Althuis M. D., Sexton M., Prybylski D. Cigarette smoking and asthma symptom severity among adult asthmatics. J Asthma. 1999 May;36(3):257–264. doi: 10.3109/02770909909075409. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. Inhaled glucocorticoids for asthma. N Engl J Med. 1995 Mar 30;332(13):868–875. doi: 10.1056/NEJM199503303321307. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J., Pedersen S., Busse W. W. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 2):S1–53. doi: 10.1164/ajrccm.157.3.157315. [DOI] [PubMed] [Google Scholar]
  4. Booth H., Richmond I., Ward C., Gardiner P. V., Harkawat R., Walters E. H. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med. 1995 Jul;152(1):45–52. doi: 10.1164/ajrccm.152.1.7599861. [DOI] [PubMed] [Google Scholar]
  5. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  6. Corticosteroid Action and Resistance in Asthma. Proceedings of a meeting. Buckinghamshire, United Kingdom, October 1995. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 2):S1–79. doi: 10.1164/ajrccm/154.2_Pt_2.S1. [DOI] [PubMed] [Google Scholar]
  7. Djukanović R., Wilson J. W., Britten K. M., Wilson S. J., Walls A. F., Roche W. R., Howarth P. H., Holgate S. T. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis. 1992 Mar;145(3):669–674. doi: 10.1164/ajrccm/145.3.669. [DOI] [PubMed] [Google Scholar]
  8. Fahy J. V., Boushey H. A. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. Eur Respir J. 1998 Jun;11(6):1240–1247. doi: 10.1183/09031936.98.11061240. [DOI] [PubMed] [Google Scholar]
  9. Faul J. L., Leonard C. T., Burke C. M., Tormey V. J., Poulter L. W. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time. Thorax. 1998 Sep;53(9):753–761. doi: 10.1136/thx.53.9.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gershman N. H., Wong H. H., Liu J. T., Fahy J. V. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. Eur Respir J. 2000 Jan;15(1):11–18. doi: 10.1183/09031936.00.15101100. [DOI] [PubMed] [Google Scholar]
  11. Jatakanon A., Lim S., Barnes P. J. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med. 2000 Jan;161(1):64–72. doi: 10.1164/ajrccm.161.1.9809100. [DOI] [PubMed] [Google Scholar]
  12. Jatakanon A., Lim S., Chung K. F., Barnes P. J. An inhaled steroid improves markers of airway inflammation in patients with mild asthma. Eur Respir J. 1998 Nov;12(5):1084–1088. doi: 10.1183/09031936.98.12051084. [DOI] [PubMed] [Google Scholar]
  13. Kuschner W. G., D'Alessandro A., Wong H., Blanc P. D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J. 1996 Oct;9(10):1989–1994. doi: 10.1183/09031936.96.09101989. [DOI] [PubMed] [Google Scholar]
  14. Laitinen L. A., Laitinen A., Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992 Jul;90(1):32–42. doi: 10.1016/s0091-6749(06)80008-4. [DOI] [PubMed] [Google Scholar]
  15. Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998 Oct 22;339(17):1194–1200. doi: 10.1056/NEJM199810223391703. [DOI] [PubMed] [Google Scholar]
  16. Marquette C. H., Saulnier F., Leroy O., Wallaert B., Chopin C., Demarcq J. M., Durocher A., Tonnel A. B. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis. 1992 Jul;146(1):76–81. doi: 10.1164/ajrccm/146.1.76. [DOI] [PubMed] [Google Scholar]
  17. McCrea K. A., Ensor J. E., Nall K., Bleecker E. R., Hasday J. D. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med. 1994 Sep;150(3):696–703. doi: 10.1164/ajrccm.150.3.8087340. [DOI] [PubMed] [Google Scholar]
  18. Pearce N., Beasley R., Pekkanen J. Role of bronchial responsiveness testing in asthma prevalence surveys. Thorax. 2000 May;55(5):352–354. doi: 10.1136/thorax.55.5.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pedersen B., Dahl R., Karlström R., Peterson C. G., Venge P. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med. 1996 May;153(5):1519–1529. doi: 10.1164/ajrccm.153.5.8630596. [DOI] [PubMed] [Google Scholar]
  20. Pin I., Gibson P. G., Kolendowicz R., Girgis-Gabardo A., Denburg J. A., Hargreave F. E., Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992 Jan;47(1):25–29. doi: 10.1136/thx.47.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pizzichini E., Pizzichini M. M., Efthimiadis A., Hargreave F. E., Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996 Jun;9(6):1174–1180. doi: 10.1183/09031936.96.09061174. [DOI] [PubMed] [Google Scholar]
  22. Popov T., Gottschalk R., Kolendowicz R., Dolovich J., Powers P., Hargreave F. E. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy. 1994 Aug;24(8):778–783. doi: 10.1111/j.1365-2222.1994.tb00990.x. [DOI] [PubMed] [Google Scholar]
  23. Sippel J. M., Pedula K. L., Vollmer W. M., Buist A. S., Osborne M. L. Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest. 1999 Mar;115(3):691–696. doi: 10.1378/chest.115.3.691. [DOI] [PubMed] [Google Scholar]
  24. Siroux V., Pin I., Oryszczyn M. P., Le Moual N., Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur Respir J. 2000 Mar;15(3):470–477. doi: 10.1034/j.1399-3003.2000.15.08.x. [DOI] [PubMed] [Google Scholar]
  25. Szefler S. J., Boushey H. A., Pearlman D. S., Togias A., Liddle R., Furlong A., Shah T., Knobil K. Time to onset of effect of fluticasone propionate in patients with asthma. J Allergy Clin Immunol. 1999 May;103(5 Pt 1):780–788. doi: 10.1016/s0091-6749(99)70420-3. [DOI] [PubMed] [Google Scholar]
  26. Turner M. O., Hussack P., Sears M. R., Dolovich J., Hargreave F. E. Exacerbations of asthma without sputum eosinophilia. Thorax. 1995 Oct;50(10):1057–1061. doi: 10.1136/thx.50.10.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Walsh L. J., Wong C. A., Cooper S., Guhan A. R., Pringle M., Tattersfield A. E. Morbidity from asthma in relation to regular treatment: a community based study. Thorax. 1999 Apr;54(4):296–300. doi: 10.1136/thx.54.4.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wedzicha J. A. The heterogeneity of chronic obstructive pulmonary disease. Thorax. 2000 Aug;55(8):631–632. doi: 10.1136/thorax.55.8.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Grunsven P. M., van Schayck C. P., Molema J., Akkermans R. P., van Weel C. Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis. Thorax. 1999 Apr;54(4):316–322. doi: 10.1136/thx.54.4.316. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES